Bluejay Diagnostics, Inc. (BJDX) stock
BJDXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$2.15−0.14 (-5.90%)
Close on Nov 17, 2026Market cap $9.63MP/E –Yield –
Earnings
Bluejay Diagnostics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
Mar 5, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2023
–
EPS, Q3 FY2023
-$2.08
-$0.15 a year earlier
Latest guidance
None
No outlook given in releases
Quarterly results
Revenue and earnings per share from each of Bluejay Diagnostics's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Mar 5, 2027Expected | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Nov 13, 2026after the close | – | – | – | Release |
| Q1 FY2026ended Mar 31, 2026 | May 7, 2026after the close | – | – | – | Release |
| Q4 FY2025ended Dec 31, 2025 | Mar 6, 2026before the open | – | – | – | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 9, 2023after the close | – | – | -$2.08 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 16, 2023before the open | – | – | -$2.75 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 10, 2023during market hours | – | – | -$0.12 | Release |
| Q4 FY2022ended Dec 31, 2022 | Mar 20, 2023after the close | – | – | – | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 8, 2022after the close | – | – | -$0.15 | Release |
| Q2 FY2022ended Jun 30, 2022 | Jul 26, 2022during market hours | $249.04K | – | -$0.10 | Release |
| Q1 FY2022ended Mar 31, 2022 | Apr 20, 2022after the close | – | – | -$0.10 | Release |
| Q4 FY2021ended Dec 31, 2021 | Mar 10, 2022before the open | – | – | -$0.09 | Release |
| Q3 FY2021ended Sep 30, 2021 | Dec 16, 2021before the open | – | – | -$0.11 | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
Bluejay Diagnostics has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When Bluejay Diagnostics puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases Bluejay Diagnostics filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- News
- Update
- Update
- Update
- Update
- Update
- News
- News
- Update
- Results
- Update
- Update
- Update
- Results
See a number that looks wrong?